Feature Article

How Climate Change Affects the Incidence, Distribution of Infectious Diseases


Scientists warn that unless there is an adequate response and proactive measures are taken, society will soon have to deal with direct and indirect effects of the changing climate on human health.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News


Herpes Simplex Virus Type 1 Common in Teens, Adults

February 12, 2018

A data brief from the Centers for Disease Control and Prevention estimates the prevalence of HSV-1 and HSV-2 antibodies among Americans using data from the 2015 to 2016 National Health and Nutrition Examination Survey.


Delafloxacin Oral and IV Therapy Now Available for Acute Bacterial Skin Infections

By February 06, 2018

Baxdela, a fluoroquinolone antibiotic, was initially approved by the FDA in June 2017.


Pediatric Mycobacterium abscessus Infection Effectively Treated With Clofazimine

By January 31, 2018

Clofazimine may be a safe and effective part of a surgical and multidrug regimen for treating children with Mycobacterium abscessus odontogenic osteomyelitis.


Adjuvant Herpes Zoster Subunit Vaccine More Cost-Effective Than Live Attenuated Vaccine

By January 30, 2018

The new adjuvant herpes zoster subunit vaccine would cost less and offer good value compared with the current live attenuated herpes zoster vaccine.


Treatment of Gram-Positive Acute Bacterial Skin Infection With Iclaprim Similar to Vancomycin

By January 29, 2018

Iclaprim may serve as an alternative treatment option for treatment of acute bacterial skin infections caused by gram-positive pathogens, including drug-resistant bacteria.


Dermatologists Should Be Aware of Herpes Zoster Risk Factors

By January 09, 2018

Women face an especially high risk for developing herpes zoster compared with men.


FDA Approves New Impetigo Treatment

By December 20, 2017

Ozenoxacin, a quinolone antimicrobial drug, works by inhibiting the bacterial DNA replication enzymes, DNA gyrase A and topoisomerase IV.


Omadacycline Effective for Acute Bacterial Skin Infection Irrespective of BMI or Diabetes

By November 20, 2017

Intravenous omadacycline and once-per-day oral omadacycline have efficacy and tolerability profiles similar to those of IV and oral linezolid in overweight/obese patients with diabetes and acute bacterial skin and skin structure infection.


Dalbavancin Effective for Treatment of Acute Bacterial Skin Infections in SIRS

By November 16, 2017

Although treating acute bacterial skin and skin structure infections in patients with systemic inflammatory response syndrome can be challenging, dalbavancin is approved by the FDA as an effective treatment.


Refractory Pityriasis Versicolor Treated With Narrow-Band UV-B Phototherapy

By November 14, 2017

Narrow-band UV-B phototherapy resulted in statistically significant reductions in clinical scores from weeks 4 through 16.

Sign up for Newsletters